Clinical Trial Update: A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy and safety of VX-993 for acute pain after bunionectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• VX-993

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Acute Pain | Phase 2 | Status: COMPLETED